"
Pharmacological Assessment of γ-Secretase Activity from Rodent and Human Brain"
written by Christine E. Oborski, Rathna Iyer, Bruce A. Maguire, Gary Bora, Kevin Atchison, Nikolay Pozdnyakov, Kathleen Wood, Christine Parker, Timothy A. Subashi, Martin Pettersson, Douglas S. Johnson, Kelly R. Bales,
published by
Neuroscience and Medicine,
Vol.3 No.2, 2012
has been cited by the following article(s):
|
[1]
|
Recent developments of small molecule γ-secretase modulators for Alzheimer's disease
RSC Medicinal Chemistry,
2020
DOI:10.1039/D0MD00196A
|
|
|
|
|
[2]
|
Development and Mechanism of γ-Secretase Modulators for Alzheimer’s Disease
Biochemistry,
2013
DOI:10.1021/bi400377p
|
|
|
|
|
[3]
|
Development and Mechanism of γ-Secretase Modulators for Alzheimer’s Disease
Biochemistry,
2013
DOI:10.1021/bi400377p
|
|
|
|
|
[4]
|
γ-Secretase Modulator (GSM) Photoaffinity Probes Reveal Distinct Allosteric Binding Sites on Presenilin
Journal of Biological Chemistry,
2013
DOI:10.1074/jbc.M112.398602
|
|
|
|